What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?

Published:2023-05-21 Issue:8 Volume:19 Page:821-825
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Favier Valentin¹^ORCID,Charriot Jérémy²³^ORCID,Crampette Louis¹,Bourdin Arnaud²³,Ahmed Engi²³⁴

Affiliation:

1. Department of ENT Surgery, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France

2. Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, Montpellier, France

3. PhyMedExp, Univ Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France

4. Laboratory of Immunoregulation and Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent, Belgium

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2023.2215986

Reference15 articles.

1. United airways disease: therapeutic aspects

2. Chronic Rhinosinusitis with Nasal Polyps and Asthma

3. Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence

4. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis

5. Allergic inflammatory memory in human respiratory epithelial progenitor cells

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey;BMJ Open;2024-05

2. Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis;Current Opinion in Allergy & Clinical Immunology;2023-11-15

3. Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma;International Journal of Molecular Sciences;2023-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3